Mount Sinai researchers identify genetic predictors of response to selinexor in multiple myeloma

Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative

Alice Soragni, an expert in patient-derived tumor organoids and functional precision oncology, has joined the University of Colorado Anschutz.

February 20, 2026

Vol.52 No.07

Clinical Roundup

Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma

Pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low mortality in carefully selected patients with pleural mesothelioma, according to a study from the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center.

February 20, 2026

Vol.52 No.07

Podcast The Directors

The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
Cancer centers fund small grants to boost morale amid low paylines

As NCI paylines drop to 4%, cancer centers are tapping into their institutional funds to provide “bridge funding,” typically in $50,000 to $100,000 increments, to enable investigators to keep their labs open until better times return—next year God willing.

January 30, 2026

Vol.52 No.04

By Paul Goldberg and Claire Marie Porter

Cancer Policy

Tens of thousands of healthcare workers strike across the country

Around 31,000 healthcare workers in California and Hawaii joined the picket line Jan. 26 as the United Nurses Associations of California/Union of Health Care  Professionals and Kaiser Permanente reached an impasse in contract negotiations.

Labcorp and Roche collaborate to expand access to advanced precision testing

Labcorp announced its first U.S. commercial laboratory with an agreement to implement Roche’s cobas Mass Spec solution. This collaboration introduces fully automated mass spectrometry into routine clinical practice—accelerating turnaround times, improving accuracy, and expanding access to advanced diagnostics for patients and providers nationwide.

January 30, 2026

Vol.52 No.04

Drugs & Targets

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

SOPHiA GENETICS and The University of Texas MD Anderson Cancer Center have entered into a collaboration to accelerate data-driven cancer care through new tools that can accurately analyze, interpret, and translate diagnostic results into clinical practice.

January 09, 2026

Vol.52 No.1

Mount Sinai researchers identify genetic predictors of response to selinexor in multiple myeloma

YOU MAY BE INTERESTED IN

Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative

Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma

The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
Cancer centers fund small grants to boost morale amid low paylines

Tens of thousands of healthcare workers strike across the country

Labcorp and Roche collaborate to expand access to advanced precision testing

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

Renew today!

Subscriber content

Never miss an issue!

Login

Mount Sinai researchers identify genetic predictors of response to selinexor in multiple myeloma

YOU MAY BE INTERESTED IN

Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative

Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma

The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)Cancer centers fund small grants to boost morale amid low paylines

Tens of thousands of healthcare workers strike across the country

Labcorp and Roche collaborate to expand access to advanced precision testing

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

Never miss an issue!

Login

The Directors: Gary Schwartz and Ramon Parsons on the best of times (for science), the worst of times (for funding)
Cancer centers fund small grants to boost morale amid low paylines